NDC 17856-0353-2 - Pharbetol Regular strength
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0353
- Requested NDC
- 17856-0353-2
- Package NDCs from labels
- 17856-0353-2, 17856-0353-1, 17856-0353-4, 17856-0353-3
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2025-06-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PHARBEST IBUPROFEN Drug Facts | ATLANTIC BIOLOGICALS CORP. | 2025-06-05 | HUMAN OTC DRUG LABEL |
| Pharbetol Regular strength - ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | 2024-04-30 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17856-0353-1 | 2024-06-26 | C162847 | 48780-1 | 1030e365-250f-111a-e063-dadaa90a10e2 | PHARBEST IBUPROFEN Drug Facts |
| 17856-0353-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-250f-111a-e063-dadaa90a10e2 | PHARBEST IBUPROFEN Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0353-1 | PharbetolRegular strength | 100 in 1 BOX, UNIT-DOSE | TABLET | 100 | 3 | |
| 17856-0353-2 | PharbetolRegular strength | 1 in 1 POUCH | TABLET | 1 | 3 | |
| 17856-0353-4 | PharbetolRegular strength | 24 in 1 BOTTLE | TABLET | 24 | 3 | |
| 17856-0353-3 | PharbetolRegular strength | 28 in 1 BOTTLE | TABLET | 28 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0353 | PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.] | 2 | Current NDC, Legacy NDC, 3 package rows | 20240627_05a91d24-b498-4ba2-a275-68b871cf62d2.zip |
| 17856-0353 | PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.] | 1 | Current NDC, Legacy NDC, 1 package rows | 20240508_bd26081c-e81e-42e8-b3da-2813863a51df.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydrocodone Bitartrate and Acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Redpharm Drug | 37451478-b961-873b-e063-6394a90a7b4e | 2025-12-11 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Sinus Relief Severe Congestion and Pain | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | CARDINAL HEALTH | 645f8075-e33f-4e1a-9249-7368261cdcb9 | 2025-12-11 | Warnings | 362O9ITL9D |
| Low Dose Aspirin | ASPIRIN | VALU MERCHANDISERS COMPANY | 746059b3-ed18-4a81-a70e-4d758e048d8e | 2025-12-11 | Warnings | M013 |
| Extra Strength Pain Relief PM | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | VALU MERCHANDISERS COMPANY | f8820150-feec-4062-85bb-14525ddf691f | 2025-12-11 | Warnings | M013 362O9ITL9D |
| Extra Strength Pain Relief | ACETAMINOPHEN | VALU MERCHANDISERS COMPANY | 005e299e-aa84-49d9-bbca-12236f865a27 | 2025-12-11 | Warnings | M013 362O9ITL9D |
| Low Dose Chewable Aspirin | ASPIRIN | VALU MERCHANDISERS COMPANY | 7d88f156-d361-4249-b70d-4bbcd5ba30b7 | 2025-12-11 | Warnings | M013 |
| Mucus Relief Sinus Severe Congestion Relief | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | VALU MERCHANDISERS COMPANY | 2e751d67-51b4-4b74-a9e8-7f3bc5636984 | 2025-12-11 | Warnings | 362O9ITL9D |
| Pressure and Pain Plus Mucus PE | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | VALU MERCHANDISERS COMPANY | 232acb86-7383-4992-b333-1e47bf7c06ad | 2025-12-11 | Warnings | 362O9ITL9D |
| Enteric Coated Aspirin | ASPIRIN | VALU MERCHANDISERS COMPANY | cc18e8e1-652e-44da-a9d7-e56cebda55a1 | 2025-12-11 | Warnings | M013 |
| Extra Strength Pain Relief | ACETAMINOPHEN | VALU MERCHANDISERS COMPANY | d4c32e70-778a-4d66-b9d0-03944a528421 | 2025-12-11 | Warnings | M013 362O9ITL9D |
| Sinus Pressure plus Pain PE | ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE | VALU MERCHANDISERS COMPANY | 72847721-9f59-4af1-8f20-dc8449742918 | 2025-12-11 | Warnings | 362O9ITL9D |
| adult low dose aspirin | ASPIRIN | VALU MERCHANDISERS COMPANY | 6fa1c707-bd42-455b-90a3-2c2a11acc683 | 2025-12-11 | Warnings | M013 |
| Cold plus Flu Severe | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | VALU MERCHANDISERS COMPANY | f6401317-0295-14b3-e053-2a95a90acbb4 | 2025-12-11 | Warnings | 362O9ITL9D |
| Head Congestion plus Flu Severe PE | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | VALU MERCHANDISERS COMPANY | f6401b58-8cf8-4067-e053-2995a90a68fc | 2025-12-11 | Warnings | 362O9ITL9D |
| 8 Hour Arthritis Pain | ACETAMINOPHEN | VALU MERCHANDISERS COMPANY | cd3a7094-ddb5-4583-a1bc-dc6ce280418c | 2025-12-11 | Warnings | 362O9ITL9D |
| Extra Strength Pain Relief | ACETAMINOPHEN | VALU MERCHANDISERS COMPANY | 5a80cb17-7731-4457-acd3-64cf4accf862 | 2025-12-11 | Warnings | M013 362O9ITL9D |
| 8 Hour Pain Relief | ACETAMINOPHEN | VALU MERCHANDISERS COMPANY | d11a7412-a543-0e34-e053-2995a90afd63 | 2025-12-11 | Warnings | 362O9ITL9D |
| Sinus Relief Pressure, Pain and Cough | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | VALU MERCHANDISERS COMPANY | b1ba37b8-4558-0808-e053-2995a90a9f5e | 2025-12-11 | Warnings | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | VALU MERCHANDISERS COMPANY | 02e3798f-86d9-64b4-e063-6294a90a29de | 2025-12-11 | Warnings | M013 362O9ITL9D |
| Regular Strength Pain Relief | ACETAMINOPHEN | VALU MERCHANDISERS COMPANY | f7e87eac-59fb-4a72-b5c6-02953112be6a | 2025-12-11 | Warnings | M013 313782 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.